Kimberly Gentile

Insider Reports History

Location
New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kimberly Gentile:

Form 4 holding SVP, Clinical Operations

Biohaven Ltd.

Security class
Stock Options (Right to buy)
Shares / value
175,000
Estimated value
Report date
27 Feb 2026
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding SVP, Clinical Operations

Biohaven Ltd.

Security class
Restricted Share Unit Award
Shares / value
7,500
Estimated value
Report date
05 Jan 2026
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding SVP, Clinical Operations

Biohaven Pharmaceutical Holding Co Ltd.

Security class
Restricted Share Unit Award
Shares / value
0
Estimated value
Report date
03 Oct 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding SVP, Clinical Operations

Biohaven Pharmaceutical Holding Co Ltd.

Security class
Stock Options (Right to Buy)
Shares / value
0
Estimated value
Report date
03 Oct 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Insider Reports Filed by Kimberly Gentile

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .